Skip to content

FDA OKs expanded use of Roche cervical cancer test

September 16, 2020

The FDA approves expanded use of Roche’s (OTCQX:RHHBY) CINtec PLUS Cytology test to be used as triage for positive cobas HPV tests performed on the automated cobas 6800 and 8800 systems in primary screening or co-testing programs.

The company says CINtec PLUS is more sensitive than a PAP smear and allows physicians to determine which HPV-positive women require further diagnostic procedures to prevent disease progression.

https://seekingalpha.com/news/3614454-fda-oks-expanded-use-of-roche-cervical-cancer-test

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: